Beth Burnside

Over the past 30 years, Beth has led teams in the areas of drug development and delivery, enhanced drug absorption, regulatory affairs, quality and corporate compliance, and intellectual property strategy. Invented products include Adderall XR®, Intuniv®, and MOXATAG®. Previously, she held executive roles with Lowery Creek Consulting, LLC., QRxPharma, MiddleBrook Pharmaceuticals (formerly Advancis Corporation), and Shire Laboratories, Inc. She is either the lead inventor or co-inventor on 34+ issued US patents and numerous related international patents. Beth holds a B.S. in Chemistry/Mathematics, an M.S. in Organic Chemistry, and a PhD in Physical-Organic Chemistry from Drexel University.